Good query examples
Report abuse
Sign up for free
Query title
1
GLP-1 agonist Use
2
Glucagon-like peptide 1 (GLP-1) agonists use among people with and without mental health conditions
3
Use of Clozapine among people with possible indication
4
Questions and Responses for selected PRO (patient reported outcomes)
5
SDoH diagnostic codes
6
Subdivide eating disorders
Drag to adjust the number of frozen columns
Requestor
Requestor email
Question
Table shell
Date requested
Status
Sites contributing data
Results
Next steps
Add results and next steps
Rebecca Rossom
Rebecca.C.Rossom@HealthPartners.Com;

How often are glucagon-like peptide 1 (GLP-1) agonists medications used by people with and without mental health conditions, and how does that vary by subgroup?

1/21/2022
Defunct
All, rx-challenged sites may elect to skip
Rebecca Rossom
Rebecca.C.Rossom@HealthPartners.Com;

How often are glucagon-like peptide 1 (GLP-1) agonists medications used by people with and without mental health conditions, and how does that vary by subgroup?

2/1/2022
Done
All
Gregory Simon
Gregory.E.Simon@kp.org;
5/4/2022
Done
BSW, EIRH, HPHC, HPI, HFHS, KPCO, KPGA, KPHI, KPNC, KPNW, KPSC, KPWA, PAMF/Sutter

Among patients experiencing a self-harm event and patients with significant suicidal ideation, only 3% had any prior clozapine use and only 1% initiated clozapine during the following 12 months.  Among patients with hospitalization or ED visit despite pharmacotherapy, 9% had any prior clozapine treatment, and 3% initiated clozapine over 12 months. Among those with significant suicidal ideation, rates of both prior clozapine treatment and subsequent initiation varied significantly by race and ethnicity, with rates among Hispanic and Non-Hispanic Black patients lower than among Non-Hispanic Whites.

Paper in press at J Clin Psych

Chris Stewart
Chris.C.Stewart@kp.org;

What are the questions (map ID to item on a scale) and answers in the PRO data, starting with CSSRS and SDOH PROs

12/14/2022
Done
KPWA, KPNC, KPNW, KPSC, KPCO, KPGA

Mapping of question_ids to items completed for GAD, AUDIT, PHQ, Columbia.

Survey of SDOH measures (only KP has in PRO tables), rates of completion where possible. Documentation in G:/...Workgroup_VDW/MHRN3quarterly/2022-04

Mapping to be used in multi-site programs. SDOH - will continue to see if administrations grow. Can map SRQ items, may want new query to count people with different types of needs, or those desiring help. Can use existing SDOH pros as covariates but need to understand the demographics of who receives these questions.

Elyse Llamocca
ellamoc1@hfhs.org;

What are the rates of recording in people with and without other MH diagnoses.

Done
KPWA, KPNW, KPSC, KPHI, KPCO, KPGA

Manuscript under review.

Frances Lynch
frances.lynch@kpchr.org;

Routine quarterly analyses show a significant increase in diagnoses of eating disorder diagnoses since 2019. Does that increase occur across all of the types of eating disorders?

3/15/2023
In progress
6 records

Alert

Lorem ipsum
Okay